EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2014 • Oxigene Inc • Biological products, (no disgnostic substances) • Massachusetts
This Employment Agreement (the “Agreement”) is entered into as of May 16, 2014 by and between OXiGENE, Inc., a Delaware corporation, (the “Company”), Dr. David Chaplin, an individual, (the “Executive”).
AMENDMENT NO. 1 TO EMPLOYMENT AGREEMENTEmployment Agreement • August 8th, 2014 • Oxigene Inc • Biological products, (no disgnostic substances)
This Amendment No. 1 to Employment Agreement (the “Amendment”) is entered into as of August 7, 2014 by and between OXiGENE, Inc., a Delaware corporation, (the “Company”), and Dr. David Chaplin, an individual (the “Executive”).
SEPARATION AGREEMENT AND RELEASESeparation Agreement • August 8th, 2014 • Oxigene Inc • Biological products, (no disgnostic substances)
THIS SEPARATION AGREEMENT AND RELEASE (“Agreement”) is made and entered into by and between Dr. Peter J. Langecker (“Employee”) and OXiGENE, Inc. (“Company”), and inures to the benefit of each of Company’s current, former and future, as applicable, parents, subsidiaries, affiliates, related entities, employee benefit plans and their fiduciaries, predecessors, successors, officers, directors, shareholders, agents, insurers, counsel, employees and assigns. The term “Parties” used in this Agreement means Company and Employee collectively.
